...
首页> 外文期刊>International Journal of Research in Medical Sciences >Autologous platelet rich plasma versus corticosteroid injection for chronic plantar fasciitis: a prospective controlled randomized comparative clinical study
【24h】

Autologous platelet rich plasma versus corticosteroid injection for chronic plantar fasciitis: a prospective controlled randomized comparative clinical study

机译:自体富血小板血浆与皮质类固醇激素注射治疗慢性足底筋膜炎:前瞻性对照随机对照临床研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Primary objective was to evaluate and compare the effectiveness of autologous platelet rich plasma (PRP) and steroid injections in chronic cases of plantar fasciitis. Methods: The present study was a prospective cohort study; 140 consecutive patients with chronic plantar fasciitis were enrolled and randomized in two groups: One receives the Platelet rich plasma (PRP) therapy (study group) and another receiving corticosteroid injection (control group). The outcomes in both groups are then evaluate and compared using visual analogue scale (VAS) and American Orthopaedic foot and Ankle Society (AOFAS) scale at 1month, 3month and 6 month post injection. The level of significance was set at p <0.05. Results: Prospective data was collected of 140 heels. The average follow up duration was about 6 months. The score on VAS scale and AOFAS improved from base line for both group but the patients received PRP therapy had a statistically significant (p<0.05) reduction in pain and improved AOFAS score at last follow up. No adverse complications were reported. Conclusions: The result of present study showed that the PRP therapy has potential to reduce pain and improve the functional outcome in cases of chronic planter fasciitis. It was found to be more effective and significantly better than corticosteroid injection.
机译:背景:主要目的是评估和比较自体富血小板血浆(PRP)和类固醇注射液在慢性足底筋膜炎病例中的有效性。方法:本研究为前瞻性队列研究。连续140例慢性足底筋膜炎患者入组并随机分为两组:一组接受富血小板血浆(PRP)治疗(研究组),另一组接受皮质类固醇注射(对照组)。然后在注射后1个月,3个月和6个月时,使用视觉模拟量表(VAS)和美国骨科足踝学会(AOFAS)量表评估和比较两组的结局。显着性水平设定为p <0.05。结果:收集了140个脚跟的前瞻性数据。平均随访时间约为6个月。两组VAS评分和AOFAS评分均较基线水平有所改善,但接受PRP治疗的患者在最后一次随访时疼痛减轻和AOFAS评分改善具有统计学意义(p <0.05)。没有不良反应的报道。结论:目前的研究结果表明,PRP疗法具有减轻慢性播种筋膜炎患者疼痛和改善功能预后的潜力。人们发现它比皮质类固醇注射剂更有效,也明显更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号